Journal of Antimicrobial Chemotherapy (1987) 20, 47-55
© 1987 The British Society for Antimicrobial Chemotherapy
research-article |
Suppression of penicillin-induced bacteriolysis of staphylococci by some anticoagulants
aRobert Koch-Institut des Bundesgesundheitsamtes Nordufer 20, D-1000 Berlin 65, Germany bThe Hebrew University, Hadassah Faculty of Dental Medicine en Karem, PO Box No. 1172, Jerusalem, Israel
accepted 20 February 1987
Heparinoids and related negatively-charged substances caused suppression of the penicillin-induced bacteriolysis of staphylococci and a higher viability rate. Furthermore, the penicillin-induced release of cell wall material was reduced by these substances. The main reason for this suppression of bacteriolysis was an inhibition of the activity of cell wall autolytic enzymes while the penicillin-specific perturbations of wall morphogenesis were not affected.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Lemaire, F. Van Bambeke, and P. M. Tulkens Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3734 - 3743. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chanteux, F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens Accumulation and Oriented Transport of Ampicillin in Caco-2 Cells from Its Pivaloyloxymethylester Prodrug, Pivampicillin Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1279 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Van Bambeke, S. Carryn, C. Seral, H. Chanteux, D. Tyteca, M.-P. Mingeot-Leclercq, and P. M. Tulkens Cellular Pharmacokinetics and Pharmacodynamics of the Glycopeptide Antibiotic Oritavancin (LY333328) in a Model of J774 Mouse Macrophages Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2853 - 2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Muller-Serieys, J. Andrews, F. Vacheron, and C. Cantalloube Tissue kinetics of telithromycin, the first ketolide antibacterial J. Antimicrob. Chemother., February 1, 2004; 53(2): 149 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Seral, F. Van Bambeke, and P. M. Tulkens Quantitative Analysis of Gentamicin, Azithromycin, Telithromycin, Ciprofloxacin, Moxifloxacin, and Oritavancin (LY333328) Activities against Intracellular Staphylococcus aureus in Mouse J774 Macrophages Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2283 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Seral, J.-M. Michot, H. Chanteux, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke Influence of P-Glycoprotein Inhibitors on Accumulation of Macrolides in J774 Murine Macrophages Antimicrob. Agents Chemother., March 1, 2003; 47(3): 1047 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ginsburg Cationic peptides from leukocytes might kill bacteria by activating their autolytic enzymes causing bacteriolysis: why are publications proposing this concept never acknowledged? Blood, April 15, 2001; 97(8): 2530 - 2532. [Full Text] [PDF] |
||||
![]() |
S. Zbaida, J. Brieland, P. Krieter, D. Loebenberg, G. Krishna, D. Horne, X. Lu, Y. Yuan, R. Hare, M. N. Cayen, et al. In Vitro Uptake of SCH 27899 (Evernimicin) by Rat Alveolar Macrophages Antimicrob. Agents Chemother., March 1, 2001; 45(3): 959 - 961. [Abstract] [Full Text] |
||||
![]() |
C. Miossec-Bartoli, L. Pilatre, P. Peyron, E.-N. N'Diaye, V. Collart-Dutilleul, I. Maridonneau-Parini, and A. Diu-Hercend The New Ketolide HMR3647 Accumulates in the Azurophil Granules of Human Polymorphonuclear Cells Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2457 - 2462. [Abstract] [Full Text] |
||||
![]() |
P. Giesbrecht, T. Kersten, H. Maidhof, and J. Wecke Staphylococcal Cell Wall: Morphogenesis and Fatal Variations in the Presence of Penicillin Microbiol. Mol. Biol. Rev., December 1, 1998; 62(4): 1371 - 1414. [Abstract] [Full Text] [PDF] |
||||



